188 filings
8-K
TENX
Tenax Therapeutics Inc
28 Mar 24
Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
8:45am
8-K
TENX
Tenax Therapeutics Inc
23 Feb 24
Other Events
4:30pm
8-K
TENX
Tenax Therapeutics Inc
20 Feb 24
Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan
8:33am
8-K
TENX
Tenax Therapeutics Inc
12 Feb 24
Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
4:46pm
8-K
TENX
Tenax Therapeutics Inc
8 Feb 24
Over 40 sites (U.S. and Canada) have agreed to participate in the LEVEL study
12:00am
8-K
amopyqd 2spysdz
6 Feb 24
Other Events
8:56am
8-K
ows7klr5 avpyd9
19 Jan 24
Other Events
4:30pm
8-K
ekft76
12 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
m8yyzm
5 Jan 24
Tenax Therapeutics Announces Reverse Stock Split
4:46pm
8-K
0xg19kr
1 Dec 23
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
496uegx8ikpd00wu
13 Nov 23
Other Events
9:10am
8-K
o5t882y98xrh03
29 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:11pm
8-K
o02i1ql
15 Aug 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
te6hszsxbbl
19 Jul 23
Other Events
4:30pm
8-K
g3f5fvht8kt 1j3u6
13 Jun 23
Submission of Matters to a Vote of Security Holders
4:10pm
8-K
1fhxs7uej6ium
31 May 23
Other Events
4:10pm
8-K
gsony638 j44mfcpi4
13 Apr 23
Tenax Therapeutics Provides 2023 Business Update
9:00am
8-K
hoa6t tir
30 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:01am
8-K
os19 bbiynlsytqeu
22 Mar 23
Other Events
4:10pm
8-K
d2nnc 4l7evpmuylc
10 Feb 23
Termination of a Material Definitive Agreement
4:31pm